Highlighting the latest activities and initiatives of prominent organizations working in the vaccine industry such as
the Bill and Melinda Gates Foundation, The Global Alliance for Vaccines and Immunization, WHO, UNICEF, the World Bank,
New Generation Vaccines details steps developing countries have taken toward research, development, manufacture, and
regulation of new vaccines for widespread use.
This text covers:
?current state-of-the-art techniques in vaccine development, including successes and the failures
?vaccine development from the bench to public health with regard to both FDA and European Union regulations
?methods for immunizing large populations and the use of needless vaccinations
?advancements in the heavily government-funded areas for developing vaccines against potential bioterror and
infectious disease agents as well as the immunization of large population bases for diseases like Anthrax, Smallpox,
Ebola, West Nile, SARS, and others
New Generation Vaccines, Fourth Edition
Editor in Chief Myron M. Levine (Ctr for Vaccine Dev, Univ of Maryland, Baltimore, MD, USA)
Editor Gordon Dougan (Sanger Institute, Cambridge, UK)
Editor Michael F. Good (Queensland Inst of Med Research, Queensland, Australia)
Editor Margaret A. Liu (ProTherImmune & Karolinska Inst, Stockholm, Sweden )
Editor Gary J. Nabel (Natl Inst of Health Vaccines Res Ctr, Bethesda, MD, USA)
Editor James P. Nataro (Ctr for Vaccine Dev, Univ of Maryland, Baltimore, MD, USA)
Editor Rino Rappuoli (Novartis Vaccines & Diagnostics, Sienne, Italy)